Study to Confirm MammoWaves Ability to Detect Breast Lesions Using Microwave Imaging in Adult Women
Led by Umbria Bioengineering Technologies · Updated on 2026-05-15
600
Participants Needed
4
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the ability of MammoWave, an innovative microwave mammogram device, to detect breast lesions in women. This investigation is multicentric, prospective, single-arm, and stratified by breast density. MammoWave uses very low power microwaves instead of traditional x-rays, making it safe for use at any age, including during pregnancy, and allows repeated exams without ionizing radiation exposure. The study aims to confirm MammoWaves effectiveness in detecting both malignant and benign breast lesions, including palpable, non-palpable, and microcalcifications.
The study will enroll up to 600 participants across several centers in Italy, Germany, and Spain. It includes two phases a preliminary phase to optimize the imaging algorithm by examining volunteers without lesions, followed by the main phase enrolling women with and without breast lesions. All participants will undergo the MammoWave exam while lying prone on the device, which takes about 10 minutes per breast. The exam includes image acquisition and data processing to generate images and parameters describing breast tissue.
Participants will have a standard breast screening alongside the MammoWave exam. Researchers will assess MammoWaves sensitivity and specificity compared to standard diagnostic methods, including mammography, ultrasound, and MRI. Patient satisfaction will also be measured through questionnaires. The primary outcome is the number of true positive results during the MammoWave procedure. The study began in January 2023 and is expected to continue until January 2027, with ongoing monitoring and comparison of results.
CONDITIONS
Brief Title
A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection
Research Team
G
Gianluigi Tiberi
S
Sabatino Tiberi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Recent radiologist report from mammography within the past month, possibly combined with ultrasound or MRI if needed
Willingness to follow study protocol and recommendations
You will not qualify if you...
Belonging to any vulnerable group
Having implanted electronic devices
Biopsy performed less than one week before the MammoWave scan
Having nipple piercings unless removed before examination
Being pregnant or breastfeeding
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Approximately 1 visit
Participants undergo the MammoWave exam where their breast is positioned in the device for image acquisition and data processing to detect breast lesions.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 4 weeks
Participants who undergo routine breast screening are observed to compare MammoWave results with standard clinical methods.
1 to 2 visits depending on clinical follow-up
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Studying Key Non-coding RNAs and Their Interaction With Chromatin Remodeling in Breast Cancer Patients
Comparing 18F-FDG and 68Ga-FAPI-46 PET Scans in Women With ER-positive Breast Cancer
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Observational Study Comparing 3D and 2D Echocardiography for Early Heart Damage Detection in Patients Receiving Anthracyclines and HER2-Targeted Cancer Therapies
Study Comparing 3D-Printed Biodegradable Breast Implants, Traditional Breast-Conserving Surgery, and Silicone Implant Reconstruction for Breast Cancer Patients
Ultrahypofractionated 5-Session Whole Breast Radiotherapy with Boost versus Standard 15-Session Radiotherapy for Breast Cancer Patients with Unfavorable Characteristics
Phase II Study Comparing 5-Day vs. 9-Day Whole Breast Radiotherapy with Boost in Early-stage Breast Cancer
Evaluating 68Ga-FAPI PETCT for Checking Axillary Lymph Node Status After Neoadjuvant Therapy in Women with Breast Cancer
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors